Healthcare Services

Global Flowable Hemostats Industry Trends and Market Growth Forecast for 2026–2030

April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Forecasted Market Value Of The Flowable Hemostats Market Across 2026–2030?

The market size for flowable hemostats has shown robust growth in recent years. It is projected to expand from $1.02 billion in 2025 to $1.1 billion in 2026, at a compound annual growth rate (CAGR) of 7.8%. This growth observed in the past can be attributed to several factors, including an increase in surgical procedure volumes, the rising adoption of advanced surgical tools, the widespread availability of gelatin-based hemostatic agents, the expansion of specialty surgical disciplines, and improved surgeon awareness regarding flowable hemostats.

The flowable hemostats market is projected to experience robust expansion in the upcoming years. This market is set to reach a valuation of $1.47 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.5%. This anticipated growth is driven by factors such as a heightened demand for quicker bleeding management, a growing emphasis on improving patient safety, the proliferation of minimally invasive and robotic surgical procedures, advancements in bioresorbable materials, and their expanding application in emergency and trauma medical situations. Key trends foreseen during this period encompass the expanded deployment of flowable hemostats in intricate surgical operations, an increase in the uptake of combination hemostatic products, a surging need for swift hemostasis options, the broadening scope of minimally invasive surgical uses, and an intensified commitment to biocompatible substances.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20552&type=smp

Which Market Drivers Are Supporting The Expansion Of The Flowable Hemostats Market?

The flowable hemostats market is expected to expand moving forward, driven by an increasing number of surgical procedures. This rise in operations is attributed to an aging population, which fuels demand for age-related surgeries, and advancements in technology that have made surgical interventions safer and more accessible. Flowable hemostats are highly valuable in surgical settings for their ability to control bleeding in areas difficult to reach or where traditional methods may be ineffective. As an illustration, a report released in June 2024 by the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based professional non-governmental organization, revealed that in 2023, the total number of surgical and non-surgical procedures increased by 3.4%, reaching 34.9 million, compared to the previous year. Thus, the growing volume of surgical procedures is a key factor propelling the growth of the flowable hemostats market.

What Segmentation Levels Are Considered In The Flowable Hemostats Market?

The flowable hemostats market covered in this report is segmented –

1) By Product: Active Hemostats, Passive Hemostats, Combination Hemostats

2) By Material: Porcine Gelatin, Bovine Gelatin

3) By Application: General Surgery, Cardiac Surgery, Vascular Surgery, Neuro And Spine Surgery, Orthopedic Surgery, Other Applications

4) By End User: Hospital And Clinics, Ambulatory Surgery Centers

Subsegments:

1) By Active Hemostats: Fibrin Sealants, Thrombin-Based Hemostats, Collagen-Based Hemostats, Biodegradable Polymer Hemostats

2) By Passive Hemostats: Gauze-Based Hemostats, Sponges and Pads, Cellulose-Based Hemostats, Granule-Based Hemostats

3) By Combination Hemostats: Fibrinogen and Thrombin Combination Products, Collagen and Fibrin Combination Products, Synthetic Combination Hemostats, Bioresorbable Combination Hemostats

How Are Trends Shaping The Direction Of The Flowable Hemostats Market?

Leading companies within the flowable hemostats market are concentrating on creating innovative hemostatic agents, including no-swell technology, to meet the changing requirements of surgical operations. This no-swell technology denotes a characteristic of a hemostatic product that halts its ability to take in fluids and enlarge, thereby rendering it appropriate for surgical applications where expansion might lead to difficulties. As an illustration, Medcura Inc., a US-based surgical technology platform, was granted Food and Drug Administration (FDA) breakthrough device designation in January 2023 for its LifeGel flowable technology, designed to manage bleeding during operations where swelling is unacceptable. Medcura’s LifeGel stands as the singular and pioneering flowable hemostatic gel developed to tackle issues uniquely associated with hemostatic swelling. Being fully hydrated and prepared for immediate application, this absorbable agent does not expand, potentially lessening dangers linked to swelling like nerve damage and paralysis. Furthermore, it proves economical, maintains antimicrobial attributes, is largely transparent, and adheres to mucous membranes, thereby presenting a more secure and efficient method for regulating hemorrhage during intricate surgical interventions.

Which Leading Firms Are Contributing To The Growth Of The Flowable Hemostats Market?

Major companies operating in the flowable hemostats market are Pfizer Inc., Johnson & Johnson Services Inc., Medtronic plc, Medline Industries Inc., Stryker Corporation, Baxter International Inc., B Braun Melsungen AG, Becton Dickinson and Company, Cook Medical Inc., Teleflex Incorporated, Mallinckrodt Pharmaceuticals, Integra LifeSciences Holdings Corporation, Gelita Medical GmbH, Ferrosan Medical Devices A/S, Marine Polymer Technologies Inc, Axio Biosolutions Private Limited, Hemostasis LLC, Aegis Lifesciences Private Limited, Medcura Health Inc, Arch Therapeutics Inc., Starch Medical Inc.

Read the full flowable hemostats market report here:

https://www.thebusinessresearchcompany.com/report/flowable-hemostats-global-market-report

How Is The Flowable Hemostats Market Distributed Across Key Geographic Regions?

North America was the largest region in the flowable hemostats market in 2025. The regions covered in the flowable hemostats market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Flowable Hemostats Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20552&type=smp

Browse Through More Reports Similar to the Global Flowable Hemostats Market 2026, By The Business Research Company

Gastrointestinal Bleeding Treatment Devices Global Market Report

https://www.thebusinessresearchcompany.com/report/gastrointestinal-bleeding-treatment-devices-global-market-report

Bleeding Disorders Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/bleeding-disorders-treatment-global-market-report

Cyclic Heavy Menstrual Bleeding Global Market Report

https://www.thebusinessresearchcompany.com/report/cyclic-heavy-menstrual-bleeding-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795